A reanalysis of research data found a high dose of popular cholesterol pill Lipitor lowers risk of heart attack and stroke in some patients with both heart disease and kidney disease, the drug's maker said Monday. Pfizer Inc. said the new analysis, which it funded ...

Biotechnology company Affymax Inc. has received a $5 million milestone payment from Takeda Pharmaceutical Co. for the development of a potential anemia treatment. Affymax said Wednesday that Takeda issued the payment for the startup of late-stage clinical testing of drug Hematide as a treatment for anemia in chronic renal ...

CHICAGO (Reuters) - Aggressive treatment with blockbuster anemia drugs may offer the best approach for kidney dialysis patients with severe anemia, U.S. researchers said on Tuesday. But aggressive treatment only made things worse for patients in the final stages of kidney disease with mild anemia, they reported in the Journal of the American Medical Association. The findings may help guide ...

Federal health advisers said Monday an organ transplant drug from Bristol-Myers Squibb Co. should be approved for patients receiving a new kidney, despite mixed results when compared with older drugs. The Food and Drug Administration drug advisory panel voted 13-5 in favor of the company's drug belatacept to prevent organ rejection in patients implanted with a new kidney. FDA ...